Summary
Because it had been reported that splenectomy produces a tumor-inhibitory effect in several transplantable tumor systems when the surgery is performed before tumor challenge, we attempted to examine this putative immunological manipulation in a therapeutic situation.
A spontaneous, autochthonous, murine breast tumor system was utilized in the present studies, and treatment was initiated in animals bearing large tumors (averaging 0.5 g). To amplify any immunological benefit ensuing from splenectomy, the tumor burden in the host was reduced by ancillary treatment with enucleative tumor surgery or with enucleative tumor surgery plus cytoreductive combination chemotherapy.
Splenectomy performed in conjunction with enucleative tumor surgery was associated with an increment of cure in each of four separate experiments in comparison to treatment with enucleative tumor surgery alone. In four of five experiments utilizing different combinations or schedules of chemotherapeutic agents following enucleative tumor surgery, the addition of splenectomy resulted in a decrease in the rate of tumor recurrence as well as an increment in the cure rate. In the fifth experiment, splenectomy resulted in a decrease in the rate of tumor recurrence, but did not effect the ultimate cure rate.
Although the nature of the immunological changes resulting from splenectomy are incompletely defined at present, these results provide encouragement in the search for immunological treatments for solid tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin, R. W., Price, M. R., Robins, R. A.: Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumor-specific antigen-antibody complexes. Nature (New Biol.) 238, 185 (1972)
Baldwin, R. W., Price, M. R., Robins, R. A.: Significance of serum factors modifying cellular immune responses to growing tumors. Br. J. Cancer 28, Suppl. 1, 37 (1973)
Bard, D. S., Pilch, Y. H.: The role of the spleen in the immunity to a chemically induced sarcoma in C3H mice. Cancer Res. 29, 1125 (1969)
Blumenschein, G. R., Cardenas, J. O., Freireich, E. J., Gottlieb, J. A.: FAC chemotherapy for breast cancer. Am. Soc. Clin. Oncol. 15, 193 (1974)
Cerny, J., Stiller, R. A.: Immunosuppression by spleen cells from moloney leukemia. Comparison of the suppressive effect on antibody response and on mitogen-induced response. J. Immunol. 115, 943 (1975)
Currie, G.: The role of circulating antigen as an inhibitor of tumor immunity in man. Br. J. Cancer 28, Suppl. 1, 153 (1973)
Currie, G. A., Basham, C.: Serum mediated inhibition of the immunological reactions of the patient to his own tumor. A possible role for circulating antigen. Br. J. Cancer 26, 427 (1972)
Ferrer, J. F.: Enhancement of the growth of sarcoma 180 in splenectomized and sham-operated AKR mice. Transplantation 6, 160 (1968a)
Ferrer, J. F.: Role of the spleen in passive immunological enhancement. Transplantation 6, 172 (1968b)
Ferrer, J. F., Mihich, E.: Antitumor effects of kethoxal-bis (thiosemicarbazone) and 6-mercaptopurine in neonatally thymectomized mice. Proc. Soc. Exp. Biol. Med. 124, 939 (1967)
Ferrer, J. F., Mihich, E.: Effect of splenectomy on the regression of transplantable tumors. Cancer Res. 28, 1116 (1968)
Hellström, I., Hellström, K. E., Sjögren, H. O.: Serum mediated inhibition of cellular immunity to methylcholanthrene induced murine sarcomas. Cell. Immunol. 1, 18 (1970)
Martin, D. S., Fugmann, R. A., Stolfi, R. L., Hayworth, P. E.: Solid tumor animal model therapeutically predictive for human breast cancer. Cancer Chemother. Rep. 5, 89 (1975)
Martin, D. S., Hayworth, P. E., Davin, E. R.: Combined modality therapy of spontaneous murine breast cancer: Effect of the chemotherapeutic regimen on cure rate and lifespan. Proc. Am. Assoc. Cancer Res. 13, 114 (1972)
Medina, D., Heppner, G.: Cell-mediated “immunostimulation” induced by mammary tumour virus-free balb/c mammary tumours. Nature 242, 329 (1973)
Milas, L., Mujagic, H.: The effect of splenectomy on fibrosarcoma “metastases” in lungs of mice. Int. J. Cancer 11, 186 (1973)
Möller, E.: Interaction between tumor and host during progressive neoplastic growth in histoincompatible recipients. J. Natl. Cancer Inst. 35, 1053 (1965)
Norbury, K. C.: Mechanisms of cell-mediated immune stimulation and inhibition. Proc. Am. Assoc. Cancer Res. 17, 145 (1976)
Old, L. J., Clarke, D. A., Benacerraf, B., Stockert, E.: Effect of prior splenectomy on the growth of sarcoma 180 in normal and bacillus calmette-guerin infected mice. Experientia 18, 335 (1962)
Pollack, S. B.: Effect of host sex and splenectomy on moloney virus-induced sarcomas. Int. J. Cancer 8, 264 (1971)
Prehn, R. T.: In: Biological Problems of Grafting. Les Congres et Colloques de L'Université de Liège. Vol. 12, p. 163 Oxford: Blackwell Scientific Publications 1959
Prehn, R. T.: The immune reaction as a stimulator of tumor growth. Science 176, 170 (1972)
Sjögren, H. O., Hellström, I., Bansal, S. C., Hellström, K. E.: Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes. Proc. Natl. Acad. Sci. 68, 1372 (1971)
Sjögren, H. O., Hellström, I., Bansal, S. C., Warner, G. A., Hellström, K. E.: Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int. J. Cancer 9, 274 (1972)
Small, M., Trainin, N.: Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor browth in vivo. Proc. Am. Assoc. Cancer Res. 17, 213 (1976)
Squartini, F., Bolis, G. B.: Mammary tumorigenesis in splenectomized mice. Tex. Rep. Biol. Med. 28, 115 (1970)
Stolfi, R. L., Fugmann, R. A., Stolfi, L. M., Martin, D. S.: Synergism between host anti-tumor immunity and combined modality therapy against murine breast cancer. Int. J. Cancer 13, 389 (1974)
Stolfi, R. L., Fugmann, R. A., Stolfi, L. M., Martin, D. S.: Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer. J. Immunol. 114, 1824 (1975)
Stolfi, R. L., Martin, D. S., Fugmann, R. A.: Spontaneous murine mammary adenocarcinoma: Model system for evaluation of combined methods of therapy. Cancer Chemother. Rep. 55, 239 (1971)
Thomson, D. M. P., Eccles, S., Alexander, P.: Antibodies and soluble tumor-specific antigens in blood and lymph of rats with chemically induced sarcomata. Br. J. Cancer 28, 6 (1973)
Author information
Authors and Affiliations
Additional information
This work was supported in part by Contract No. N01-CM-73703 and Grant IR01CA-14768-01A1, both from the National Cancer Institute, National Institutes of Health, Department of Health, Education and Welfare, USA, and in part by a grant from the Chemotherapy Foundation of New York, Inc.
Rights and permissions
About this article
Cite this article
Stolfi, R.L., Stolfi, L.M., Fugmann, R.A. et al. Augmented therapeutic results elicited by splenectomy in combined modality treatment of spontaneous murine breast cancer. Cancer Immunol Immunother 3, 137–143 (1977). https://doi.org/10.1007/BF00200072
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00200072